Identification of APOH polymorphisms as common genetic risk factors for venous thrombosis in the Chinese population

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Thrombosis and Haemostasis

• Publication date

  2014-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/jth.12679PMID 25081279
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic determinants of plasma β2‐glycoprotein I levels: a genome‐wide association study in extended pedigrees from Spain

  2013cited by this paper
• β2‐Glycoprotein I binds to thrombin and selectively inhibits the enzyme procoagulant functions

  2013cited by this paper
• Common genetic risk factors for venous thrombosis in the Chinese population.

  2013cited by this paper
• Venous thrombosis risk assessment in medical inpatients: the medical inpatients and thrombosis (MITH) study

  2013cited by this paper
• Genetic Background Analysis of Protein C Deficiency Demonstrates a Recurrent Mutation Associated with Venous Thrombosis in Chinese Population

  2012cited by this paper
• PROC c.574_576del polymorphism: a common genetic risk factor for venous thrombosis in the Chinese population

  2012cited by this paper
• Long-Term Survival in a Large Cohort of Patients with Venous Thrombosis: Incidence and Predictors

  2012cited by this paper
• Multiple SNP testing improves risk prediction of first venous thrombosis.

  2012cited by this paper
• Mortality and inherited thrombophilia: results from the European Prospective Cohort on Thrombophilia

  2012cited by this paper
• Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism

  2011cited by this paper
• GenBank

  2011cited by this paper
• Recurrent venous thrombosis, post‐thrombotic syndrome and quality of life after catheter‐directed thrombolysis in severe proximal deep vein thrombosis

  2011cited by this paper
• Genetic risk prediction in complex disease

  2011cited by this paper
• β2‐Glycoprotein I: evolution, structure and function

  2011cited by this paper
• Risk assessment for recurrent venous thrombosis.

  2011cited by this paper
• Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome.

  2011cited by this paper
• β₂-Glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model.

  2011cited by this paper
• Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome.

  2010cited by this paper
• Protein S inherited qualitative deficiency: novel mutations and phenotypic influence

  2010cited by this paper
• Functional and genetic characterization of the promoter region of apolipoprotein H (β2‐glycoprotein I)

  2010cited by this paper
• Risk assessment for recurrent venous thrombosis.

  2010cited by this paper
• Association between beta2-glycoprotein I plasma levels and the risk of myocardial infarction in older men.

  2009cited by this paper
• Beta2-glycoprotein I protects thrombin from inhibition by heparin cofactor II: potentiation of this effect in the presence of anti-beta2-glycoprotein I autoantibodies.

  2008cited by this paper
• Gene variants associated with deep vein thrombosis.

  2008cited by this paper
• Past and future of genetic research in thrombosis

  2007cited by this paper
• beta2-Glycoprotein I inhibits von Willebrand factor dependent platelet adhesion and aggregation.

  2007cited by this paper
• A nonsense polymorphism in the protein Z-dependent protease inhibitor increases the risk for venous thrombosis.

  2006cited by this paper
• SNPStats: a web tool for the analysis of association studies

  2006cited by this paper
• Circulating levels of β2-glycoprotein I in thrombotic disorders and in inflammation

  2006cited by this paper
• Roles of protease-activated receptors in a mouse model of endotoxemia.

  2006cited by this paper
• Inflammatory Cytokines as Risk Factors for a First Venous Thrombosis: A Prospective Population-Based Study

  2006cited by this paper
• Heterogeneity of the apolipoprotein H*3 allele and its role in affecting the binding of apolipoprotein H (β2-glycoprotein I) to anionic phospholipids

  2004cited by this paper
• A functional polymorphism at the transcriptional initiation site in beta2-glycoprotein I (apolipoprotein H) associated with reduced gene expression and lower plasma levels of beta2-glycoprotein I.

  2003cited by this paper
• A haplotype map of the human genome

  2003cited by this paper
• The Epidemiology of Venous Thromboembolism

  2003cited by this paper
• A haplotype map of the human genome.

  2003cited by this paper
• Protein S Gla-domain mutations causing impaired Ca(2+)-induced phospholipid binding and severe functional protein S deficiency.

  2002cited by this paper
• Crystal structure of human β2‐glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome

  1999cited by this paper
• Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome.

  1999cited by this paper
• Genetic variation in the apolipoprotein H (β2-glycoprotein I) gene affects plasma apolipoprotein H concentrations

  1999cited by this paper
• Identification of structural mutations in the fifth domain of apolipoprotein H (beta 2-glycoprotein I) which affect phospholipid binding.

  1997cited by this paper
• Heterogeneity of the apolipoprotein H * 3 allele and its role in affecting the binding of apolipoprotein H (β2-glycoprotein I) to anionic phospholipids

  1995cited by this paper
• Power and sample size calculations. A review and computer program.

  1990cited by this paper
• beta 2-Glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway.

  1985cited by this paper

• Genetic associations of circulating plasma proteins with cardiometabolic diseases

  2026cites this paper
• Protection of β2GPI Deficient Mice from Thrombosis Reflects a Defect in PAR3-facilitated Platelet Activation

  2023cites this paper
• Construction and optimization of a polygenic risk model for venous thromboembolism in the Chinese population

  2023cites this paper
• The association of APOH and NCF1 polymorphisms on susceptibility to recurrent pregnancy loss in women with antiphospholipid syndrome

  2023cites this paper
• Clinical Research Investigating Alzheimer’s Disease in China: Current Status and Future Perspectives Toward Prevention

  2022cites this paper
• Antigens and Antibodies of the Antiphospholipid Syndrome as New Allies in the Pathogenesis of COVID-19 Coagulopathy

  2022cites this paper
• Βeta-2-glycoprotein I exerts antithrombotic function through its domain V in mice.

  2021cites this paper
• Beta‐2‐Glycoprotein‐I Deficiency Could Precipitate an Antiphospholipid Syndrome‐like Prothrombotic Situation in Patients With Coronavirus Disease 2019

  2021cites this paper
• Didelphis albiventris: an overview of an unprecedented transcriptome sequencing of the white-eared opossum

  2020influential citation
• Cystathionine β-synthase deficiency: different changes in proteomes of thrombosis-resistant Cbs−/− mice and thrombosis-prone CBS−/− humans

  2020cites this paper
• Didelphis albiventris: an overview of unprecedented transcriptome sequencing of the white-eared opossum

  2019influential citation
• Candidate gene and pathway analyses identifying genetic variations associated with prasugrel pharmacokinetics and pharmacodynamics.

  2019cites this paper
• Global genetic diversity of human apolipoproteins and effects on cardiovascular disease risk

  2018cites this paper
• What is currently known about the genetics of venous thromboembolism at the dawn of next generation sequencing technologies

  2018cites this paper
• Genome-wide significant results identified for plasma apolipoprotein H levels in middle-aged and older adults

  2016cites this paper
• Platelets Proteomic Profiles of Acute Ischemic Stroke Patients

  2016cites this paper